New imaging tool may spot chemo damage early
NCT ID NCT05731375
First seen May 13, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This completed study tested whether a non-invasive MRI technique (31P-MRS) can monitor changes in energy production in the heart and calf muscles of cancer patients receiving chemotherapy with anthracyclines or platinum drugs. Twelve adult cancer patients underwent three imaging sessions during their treatment. The goal was to see if this scan could detect early signs of muscle and heart damage caused by chemotherapy, without any direct treatment benefit for participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPEUTIC TOXICITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diakonessenhuis
Utrecht, Utrecht, 3582 KE, Netherlands
-
Meander Medisch Centrum
Amersfoort, Utrecht, 3813 TZ, Netherlands
-
UMC Utrecht
Utrecht, Utrecht, 3584CX, Netherlands
-
Ziekenhuis Gelderse Vallei
Ede, Gelderland, 6716 RP, Netherlands
Conditions
Explore the condition pages connected to this study.